113 related articles for article (PubMed ID: 35777237)
1. Comparison of PET/CT SUV metrics across different clinical software platforms.
Wilson CM; Selwyn RG; Elojeimy S
Clin Imaging; 2022 Sep; 89():104-108. PubMed ID: 35777237
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.
Zwezerijnen GJC; Eertink JJ; Ferrández MC; Wiegers SE; Burggraaff CN; Lugtenburg PJ; Heymans MW; de Vet HCW; Zijlstra JM; Boellaard R
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):486-493. PubMed ID: 36166080
[TBL] [Abstract][Full Text] [Related]
3. Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
Schoen M; Braun T; Manava P; Ludwigs S; Lell M
Nuklearmedizin; 2018 Apr; 57(2):50-55. PubMed ID: 29590675
[TBL] [Abstract][Full Text] [Related]
4. Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population.
Kershah S; Partovi S; Traughber BJ; Muzic RF; Schluchter MD; O'Donnell JK; Faulhaber P
Mol Imaging Biol; 2013 Dec; 15(6):776-85. PubMed ID: 23632951
[TBL] [Abstract][Full Text] [Related]
5. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
6. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
7. Assessment of biological parameters in head and neck cancer based on in vivo distribution of
Cegla P; Kazmierska J; Gwozdz S; Czepczynski R; Malicki J; Cholewinski W
Tumori; 2020 Feb; 106(1):33-38. PubMed ID: 31446858
[TBL] [Abstract][Full Text] [Related]
8. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC).
Bernstine H; Domachevsky L; Nidam M; Goldberg N; Abadi-Korek I; Shpilberg O; Groshar D
Medicine (Baltimore); 2018 Apr; 97(16):e0490. PubMed ID: 29668631
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease.
Tsuji S; Iwamoto N; Horai Y; Fujikawa K; Fujita Y; Fukui S; Ideguchi R; Michitsuji T; Nishihata S; Okamoto M; Tsuji Y; Endo Y; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Igawa T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kudo T; Kawakami A
Clin Exp Rheumatol; 2021; 39(6):1338-1344. PubMed ID: 33506750
[TBL] [Abstract][Full Text] [Related]
13. Does whole-body Patlak
Fahrni G; Karakatsanis NA; Di Domenicantonio G; Garibotto V; Zaidi H
Eur Radiol; 2019 Sep; 29(9):4812-4821. PubMed ID: 30689031
[TBL] [Abstract][Full Text] [Related]
14. Correlation of
Mayoral M; Paredes P; Saco A; Fusté P; Perlaza P; Tapias A; Fernandez-Martinez A; Vidal L; Ordi J; Pavia J; Martinez-Roman S; Lomeña F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):80-86. PubMed ID: 28869177
[TBL] [Abstract][Full Text] [Related]
15. Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume.
Rockall AG; Avril N; Lam R; Iannone R; Mozley PD; Parkinson C; Bergstrom D; Sala E; Sarker SJ; McNeish IA; Brenton JD
Clin Cancer Res; 2014 May; 20(10):2751-60. PubMed ID: 24573555
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
[TBL] [Abstract][Full Text] [Related]
17. Effect of blood glucose level on standardized uptake value (SUV) in
Eskian M; Alavi A; Khorasanizadeh M; Viglianti BL; Jacobsson H; Barwick TD; Meysamie A; Yi SK; Iwano S; Bybel B; Caobelli F; Lococo F; Gea J; Sancho-Muñoz A; Schildt J; Tatcı E; Lapa C; Keramida G; Peters M; Boktor RR; John J; Pitman AG; Mazurek T; Rezaei N
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):224-237. PubMed ID: 30350009
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
19. Clinical respiratory motion correction software (reconstruct, register and averaged-RRA), for
Bouyeure-Petit AC; Chastan M; Edet-Sanson A; Becker S; Thureau S; Houivet E; Vera P; Hapdey S
Br J Radiol; 2017 Feb; 90(1070):20160549. PubMed ID: 27936893
[TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.
Jackson T; Chung MK; Mercier G; Ozonoff A; Subramaniam RM
Nucl Med Commun; 2012 Mar; 33(3):305-12. PubMed ID: 22227560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]